SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders

1. Elevation Oncology is being investigated regarding a sale to Concentra Biosciences. 2. Shareholders of Elevation will receive $0.36 per share plus contingent rights. 3. The deal includes rights to net cash exceeding $26.4 million. 4. Halper Sadeh LLC seeks to ensure shareholder rights and potentially increase transaction benefits. 5. Investors may contact Halper Sadeh for legal options regarding the sale.

M&A

70

5m saved

Insight

Article

FAQ

Why Neutral?

The share price offer is relatively low, lacking bullish momentum.

How important is it?

Shareholder actions and potential adjustments in deal terms may influence price shortly.

Why Short Term?

Immediate impact from the deal announcement but unclear longer-term effects.

Related Companies

KNW CRKN

Investor Rights Law Firm Investigating Securities Violations

NEW YORK, June 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Know Labs, Inc. (NYSE American: KNW)

's sale to Goldeneye 1995 LLC. If you are a Know Labs shareholder, click here to learn more about your legal rights and options.

Elevation Oncology, Inc. (NASDAQ: ELEV)

's sale to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing. If you are an Elevation shareholder, click here to learn more about your rights and options.

Crown Electrokinetics Corp. (OTCMKTS: CRKN)

's sale to Crown EK Acquisition LLC for $3.15 per share. If you are a Crown Electrokinetics shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email info@halpersadeh.com or contact@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

info@halpersadeh.com

contact@halpersadeh.com

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP